Printer-friendly versionPrinter-friendly version

Highlight underserved for screening, prevention and treatment of viral hepatitis B and C in Europe.

March 10-11, 2016- Ljubljana, Slovenia

Objectives of the meeting:

  • Define and identify underserved groups for screening, prevention and treatment (person who ignore their status, unidentified patients,…);
  • Identify, present and discuss lessons learnt from initiatives taken in several countries, related to existing models to reach underserved and hard to reach groups, for prevention as well as diagnosis, screening and treatment;
  • Find missed opportunities in existing public health settings to improve screening, prevention and treatment in underserved groups;
  • Discuss the impact of neglecting/highlighting underserved groups on public health;
  • Discuss strategies to improve access for hard to reach and underserved groups towards screening/diagnosis/treatment programs and immunization programmes – including how to liaise all programs for these groups;
  • Identify challenges for research and advocacy for these underserved groups.

Background document - 2.4Mb(.pdf)

Thursday, March 10, 2016

SESSION 1 : OPENING AND OBJECTIVES
Chairs: Mojca Matičič – Tatjana Reic

09:00-09:30

  • Welcome and opening;
  • Introduction of the participants;
  • Welcome word by Mojca Gobec, Director General, Ministry of Health of Slovenia Public Health Directorate, presented by Mojca Matičič;
  • Objectives of the meeting;
  • Review of the programme.

SESSION 2: INTERNATIONAL ORGANISATIONS INVOLVED IN HEPATITIS PREVENTION AND CONTROL AND RECOMMENDATIONS

Part 2.1 International organisations

09:30-09:45 Correlation Network - 2.1Mb (.pdf)
Eberhard Schatz

09:45-10:00 International Centre for Migration Health and Development
Manuel Carballo

10:00-10:15 Health Without Barriers (HWBs) – How screening and testing of prisoners can be improved: an European example from Health Without Barriers (HWBs) - The European Federation for Prison Health - 814Kb(.pdf)
Sergio Babudieri

10:15-10:35 EMCDDA European Monitoring Centre for Drugs and Drug Addiction + a systematic review of prevalence and cost-effectiveness of screening hepatitis B and C in Europe -1.5Mb(.pdf)
Lucas Wiessing

10:35-10:50 Discussion

10:50-11:10 Coffee break

Chairs: Fiona Godfrey and David Goldberg

Part 2.2 Recommendations

Migrants

11:10-11:25 WHO Recommendations Migrants and health - 475Kb(.pdf)
Antons Mozalevskis

IDU

11:25-11:45 Recommendations for the management of hepatitis C virus infection among people who inject drugs - 1.1Mb (.pdf)
Dalgard Olav

11:45-12:05 Treatment of chronic hepatitis C in drug users: ethic, successful and useful - 3.1Mb(.pdf)
André Remy

12:05 - 12:20 Discussion

12:20 - 13:30 Lunch

SESSION 3 :SCREENING: UNIDENTIFIED CARRIERS
Chairs: Heléne Norder and Vana Papaevangelou

part 3.1 Methodology of screening (adapted diagnostics) in underserved groups and in general population

13:30-13:50 Using mass media and the Internet as tools to diagnose hepatitis C infections in the general population. - 830kb (.pdf)
Freke Zuure

13:50-14:10 Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots. - 1.4Mb (.pdf)
Slim Fourati

Part 3.2: Screening initiatives taken in the general population and different underserved groups

Prisoners

14:10 - 14:30 Hepatitis C in European prisons: a call for an evidence-informed response. - 381Kb (.pdf)
Amber Arain

Migrants

14:30 - 14:50 Belgium Hepatitis screening project to reach asian migrants “China aan de Schelde” - 3.2Mb (.pdf)
Thomas Vanwolleghem

14:50 - 15:10 HepatitisB/C screening, retrieval of patients and organization of hepatitis care in Arnhem region, The Netherlands. - 1.3Mb (.pdf)
Clemens Richter

15:10 - 15:30 Hprolipsis: HBV & HCV infections among Roma and migrants in Greece. - 0.9Mb (.pdf)
Vana Sypsa

15:30 - 15:50 Migrant screening for viral hepatitis: two feasible strategies in universities and workplaces in Grampain, Scotland. - 750Kb (.pdf)
Maria Rossi

15:50 - 16:05 Discussion

16:05 - 16:25 Coffee break

SESSION 4 :TREATMENT
Chairs: Daniel Shouval and Rui Tato Marinho

part 4.1 Treatment projects and initiatives taken in different underserved groups

16:25 - 16:45 Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries - 2.1Mb (.pdf)
Mojca Matičič

16:45 - 17:05 Rolling up HCV treatment programs for PWIDs in Ukraine - 2.1Mb
Ludmila Maistat

17:05 - 17:25 A national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in Slovenia - 1.6Mb (.pdf)
Mojca Matičič

17:25 - 17:45 Shared Addiction Care Copenhagen (SACC)-project. better practices at the micro level across the whole HCV pathway from diagnosing, further evaluation when infected to HCV-treatment and follow up - 702Kb (.pdf)
Marianne Linnet

17:45 - 18:05 Cost effectiveness of treating active PWID and the challenges of treating the underserved of the underserved - 717Kb (.pdf)
David Goldberg

18:05 - 18:20 Discussion

SESSION 5 :PREVENTION

18:20 - 18:40 Underserved for Hepatitis B immunization: Hepatitis B Vaccination for Adults with Diabetes Mellitus Recommendations of the Advisory Committee on Immunization Practices (ACIP) - 520Kb (.pdf)
Noele P. Nelson

Friday 11 March 2016

SESSION 5 (CONT) : PREVENTION
Chairs: Angela Dominguez and Antons Mozalevskis

Part 5.1: Identify underserved groups (no/low vaccination coverage)

08:30 - 08:50 Hepatitis B: are at-risk individuals vaccinated if screened and found negative for HBV? Results of an online survey conducted in six EU countries - 694Kb (.pdf)
Miriam Levi

5.2 Prevention initiatives taken in different underserved groups

Migrants

08:50 - 09:10 Migrant's access to immunization in Mediterranean Countries and Immunization programmes in Roma population in Bulgaria - 547Kb (.pdf)
Mira Kojouharova

IDU

09:10 - 09:30 High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants-Is Prevention Failing - 1Mb (.pdf)
Cinta Folch

09:30 - 09:45 Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study - 765Kb (.pdf)
Patrizia Carrieri

Prisoners

09:45 - 10:00 HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions - 566kb (.pdf)
Patrizia Carrieri

10:00 - 10:20 An audit of hepatitis C service provision in a representative sample of prisons in England - 551kb (.pdf)
Clare Humphreys

10:20 - 10:40 Discussion

10:40 - 11:00 Coffee break

Chairs: Mark Kane and Pierre Van Damme

Part 5.2 (cont.): Prevention initiatives taken in different underserved groups

Sex Workers

11:00 - 11:20 Hepatitis B vaccination and HCV screening: access to sex workers in Flanders – Healthcare and social care for sex workers (GHAPRO) - 1.7Mb (.pdf)
Tine Cornelissen

Others

11:20 - 11:40 Saunas programme: an outreach approach to diagnose and prevent hepatitis in a vulnerable population of the city of Barcelona - 1Mb (.pdf)
Sandra Manzanares

11:40 - 12:00 Hepatitis initiatives in vulnerable populations in Albania - 745Kb (.pdf)
Elona Kureta

12:00 - 12:20 Mobile vaccination team in Flandres, Belgium - 546Kb (.pdf)
Els Van de Mieroop

12:20 - 12:40 Tailoring Immunization Programmes (TIP) – An example of tailoring communication on vaccinations targeting hard-to-serve communities in Sweden - 1.6Mb (.pdf)
Karina Godoy

12:40 - 13:00 Discussion

13:00 - 13:30 Final Meeting Discussion on strategies to improve access for hard to reach and underserved groups towards screening/diagnosis/treatment programs and immunization programmes – including how to liaise all programs for these groups

13:30 - 14:30 Lunch

SESSION 6: CONCLUSIONS OF THE MEETING
Chairs: Daniel Lavanchy and Wolfgang Jilg

14:30 - 15:30 Presentation of the VHPB meeting conclusions - 123kb (.pdf)
David FitzSimons

Tags: